Upstream Bio
Company

Upstream Bio

Biotechnology Research 890 Winter St 66 employees
Employees
66
Contacts
4
Emails
4
Phones
3

Upstream Bio Overview

Headquarters
890 Winter St
Industry
Biotechnology Research
Employees
66
Founded
2021
Funding
200.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Upstream Bio

We are advancing verekitug, a clinical-stage monoclonal antibody targeting an upstream driver of inflammatory response. Our experienced team is committed to leveraging verekitug’s unique mechanism of action to improve the treatment options for millions of patients living with severe inflammatory diseases.

Upstream Bio Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Upstream Bio Org Chart

Sample employees and titles
Name Title Contact
Ron Renaud President & CEO - Kailera Therapeutics
Email Phone
Rebecca Nuzzo
Email
Stacy Petti Price Chief Technology & Manufacturing
Email Phone
Michael Gray Chief Financial and Chief Operating
Email Phone

Employees by Management Level

Executive 3 profiles

Compare Similar Companies to Upstream Bio